Maintaining Your Results With GLP-1s

Reaching your goal weight is a genuine achievement - and you deserve to feel proud of yourself.

But it can also feel unexpectedly unsettling. Many people find that the closer they get to their target, the more anxious they become about what comes next.

What happens to the medication? Will the weight come back? What if I need to start all over again?

These are entirely normal questions, and you are far from alone in asking them. This guide is here to answer them honestly, set out your options clearly, and remind you that our support at Rightangled does not stop simply because you have reached a certain number on the scale.

Understanding Obesity

Obesity is recognised by the World Health Organisation as a chronic, relapsing medical condition. That framing matters because it changes how we think about treatment.

Consider blood pressure medication as an analogy. When someone stops taking it, their blood pressure does not remain stable - it typically begins to rise again.

GLP-1 medications work in a similar way. Treatments like Mounjaro and Wegovy help regulate appetite, reduce food noise, and improve blood sugar control. But when you stop taking them, your body's baseline hunger signals gradually return.

This is why, for many people, ongoing treatment becomes part of a longer-term management plan - in the same way that continuing blood pressure medication does. The decision to stop or continue GLP-1 treatment deserves careful thought, rather than an automatic stop the moment you reach your goal.

What Happens When You Reach Your Goal Weight?

Reaching your goal weight marks the beginning of your maintenance phase. At Rightangled, your treatment will not be stopped automatically. What happens next is your decision. There is no single right answer, and there is no pressure to take any particular path.

It is worth knowing that small movements on the scales are completely normal. Hydration levels, hormones, and what you ate the day before can all shift the number by a kilogram or more. A slight increase does not mean something has gone wrong, and it does not automatically mean your dose needs to change.

Think of maintenance as a range, not a single fixed number.

Your Maintenance Options

Stay on your current dose

If your current dose is working well and you are tolerating it comfortably, you can simply continue. Many people choose this option to preserve their results and support longer-term health. You can find out more about the treatments we offer on our weight management page.

Taper to a lower dose

Some people prefer a lighter maintenance approach. A reduced dose can still provide meaningful appetite support and weight stability - often with fewer side effects and at a lower cost. You can explore this at your own pace with guidance from the Rightangled clinical team.

Take a treatment break or stop altogether

If you decide to pause or stop treatment, that is completely fine. There is no pressure to remain on medication, and no judgement if you choose to return at a later point. Whatever you decide, it does not have to be permanent.

About the BMI Threshold

At Rightangled, we currently prescribe GLP-1 treatments down to a BMI of 21. If your BMI falls below this level, we will need to pause treatment for your safety.

You do not need to aim for a BMI below 25 to be in a healthy maintenance phase. If you feel well and in good health at a BMI of 26 or 27, that is a completely valid place to maintain. Your goals are your own.

For reference, BMI categories based on NHS guidelines are as follows:

Taking a Break and Coming Back

Many people will pause treatment at some point - to see how they feel without it, for financial reasons, or simply to try. This is a natural part of the journey. You are always welcome back, without judgement and without unnecessary barriers.

Importantly, if you do restart, you will not need your BMI to be 30 or above again to be eligible.

Here is how we approach restart doses at Rightangled:

Supporting Yourself Through the Transition

Whether you stay on medication or decide to stop, the habits you have built are your most valuable long-term asset.

Prioritise protein and fibre. Both support feelings of fullness, which becomes especially important if your GLP-1 support is reduced or discontinued.

Keep moving. Strength training in particular helps preserve muscle mass, which supports your metabolism even at rest.

Trust yourself to notice changes. Increased food noise, feeling hungrier between meals, or gradual weight gain are signals worth paying attention to early. If you ever feel you would benefit from additional support, returning to treatment is always an option.

We're Here for the Long Term

Maintenance is an ongoing process rather than a single destination, and it can be emotionally demanding. The anxiety many people feel at this stage is real and valid. We do not expect you to have everything figured out the moment you reach your goal weight.

Whatever path you choose, it is yours to make. If you ever want to return to treatment after stopping, the Rightangled team will make that as simple and straightforward as possible.

You can explore your options, check eligibility, or speak to our clinical team at any time via our weight management page. If you have questions about Wegovy or Mounjaro specifically, you can also visit the individual product pages for more information.

Article Summary

Stopping or pausing GLP-1 treatment is a completely valid choice. There is no expectation to stay on medication indefinitely, and returning later is straightforward and free from judgement.
Weight fluctuations are normal and do not mean something has gone wrong. Maintenance is a range, not a fixed number.
Medication is one part of managing obesity, but the lifestyle habits you have built matter - and they work alongside treatment, not instead of it.

References

World Health Organization. Obesity and overweight. 2025 Dec 8. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
West S, Scragg J, Aveyard P, et al. Weight regain after cessation of medication for weight management: systematic review and meta-analysis. BMJ. 2026;392:e085304.

Maintaining Your Results With GLP-1s | Rightangled